Market revenue in 2023 | USD 10.4 million |
Market revenue in 2030 | USD 24.7 million |
Growth rate | 13.1% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Kits & Reagents, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Lonza Group Ltd, Merck KGaA, Charles River Laboratories International Inc, Asahi Kasei Corp, Sartorius AG, Eurofins Scientific SE, PromoCell GmbH, ATCC, InvivoGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mycoplasma testing market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 57.69% in 2023. Horizon Databook has segmented the Denmark mycoplasma testing market based on instruments, kits & reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
Denmark is one of the fastest-growing European countries for biotech investment. Danish biotech businesses secured venture capital investment of USD 434 million in 2021, an 11.8-fold increase over the past 5 years, demonstrating one of the fastest growth rates in Europe. These investments are anticipated to drive the demand for biotechnology tools, including mycoplasma testing solutions, thereby boosting market growth.
Furthermore, biotechnology companies in the country are focusing on expanding their manufacturing capacities, boosting the demand for mycoplasma testing. For instance, in June 2022, Fujifilm announced that it would invest USD 1.6 billion to expand its cell culture manufacturing facility in the country. This expansion was expected to make Fujifilm the largest end-toend CDMO in Europe. Such programs are likely to fuel market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark mycoplasma testing market , including forecasts for subscribers. This country databook contains high-level insights into Denmark mycoplasma testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account